APA (7th ed.) Citation

J, R., K, E., B, W., CM, S., K, H., EJ, E., . . . RB, L. (2023). In vivo activity of the dual PI3Kδ and PI3Kγ inhibitor duvelisib against pediatric acute lymphoblastic leukemia xenografts. Pediatric blood & cancer, 70(8), e30398. https://doi.org/10.1002/pbc.30398

Chicago Style (17th ed.) Citation

J, Randall, et al. "In Vivo Activity of the Dual PI3Kδ and PI3Kγ Inhibitor Duvelisib Against Pediatric Acute Lymphoblastic Leukemia Xenografts." Pediatric Blood & Cancer 70, no. 8 (2023): e30398. https://doi.org/10.1002/pbc.30398.

MLA (9th ed.) Citation

J, Randall, et al. "In Vivo Activity of the Dual PI3Kδ and PI3Kγ Inhibitor Duvelisib Against Pediatric Acute Lymphoblastic Leukemia Xenografts." Pediatric Blood & Cancer, vol. 70, no. 8, 2023, p. e30398, https://doi.org/10.1002/pbc.30398.